GW
DGX icon

GW & Wade’s Quest Diagnostics DGX Stock Holding History

GW & Wade’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$416K Sell
3,018
-165
-5% -$21.7K 0.01% 315
2023
Q3 		$388K Buy
+3,183
New +$424K 0.01% 301
2023
Q2 		– Sell
-2,691
Closed -$381K – 388
2023
Q1 		$381K Buy
2,691
+123
+5% +$17.6K 0.01% 285
2022
Q4 		$402K Buy
2,568
+82
+3% +$11.8K 0.02% 281
2022
Q3 		$305K Buy
2,486
+138
+6% +$18.2K 0.01% 297
2022
Q2 		$312K Buy
+2,348
New +$320K 0.01% 302
2022
Q1 		– Sell
-1,280
Closed -$221K – 398
2021
Q4 		$221K Buy
+1,280
New +$195K 0.01% 370
2018
Q1 		– Sell
-4,694
Closed -$462K – 234
2017
Q4 		$462K Buy
4,694
+10
+0.2% +$948 0.05% 142
2017
Q3 		$439K Buy
4,684
+3
+0.1% +$318 0.05% 151
2017
Q2 		$520K Buy
4,681
+6
+0.1% +$634 0.07% 133
2017
Q1 		$459K Buy
4,675
+91
+2% +$8.68K 0.06% 143
2016
Q4 		$421K Sell
4,584
-68
-1% -$5.86K 0.07% 142
2016
Q3 		$394K Buy
4,652
+71
+2% +$5.96K 0.07% 141
2016
Q2 		$373K Buy
4,581
+296
+7% +$22.5K 0.06% 169
2016
Q1 		$306K Buy
+4,285
New +$287K 0.06% 164

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

GW & Wade's DGX Position: Q4 2023 in Review

GW & Wade reduced its Quest Diagnostics (DGX) stake by 5.2% in Q4 2023, selling an estimated $21.7K and leaving 3,018 shares worth $416K. The position accounts for 0.01% of the portfolio, ranked #315.

GW & Wade first reported a position in DGX in Q1 2016 and has held it in 15 quarters since. The position peaked at $520K in Q2 2017. 827 funds tracked by Wall St. Rank hold DGX as of Q4 2023.

  • GW & Wade held 3,018 shares of Quest Diagnostics worth $416K as of Q4 2023.
  • GW & Wade sold 165 Quest Diagnostics shares in Q4 2023, an estimated $21.7K.
  • Quest Diagnostics made up 0.01% of GW & Wade's portfolio in Q4 2023, its #315 holding.
  • GW & Wade first reported a position in Quest Diagnostics in Q1 2016 and has held it in 15 quarters since.
  • GW & Wade's Quest Diagnostics position peaked at $520K in Q2 2017.
  • 827 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2023.

Based on GW & Wade's 13F filing for Q4 2023, filed 8 Feb 2024.